Stifel Financial’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Sell |
115,941
-511
| -0.4% | -$741 | ﹤0.01% | 3290 |
|
|
2025
Q1 | $161K | Buy |
116,452
+6,752
| +6% | +$9.32K | ﹤0.01% | 3222 |
|
|
2024
Q4 | $333K | Buy |
109,700
+10,567
| +11% | +$32.1K | ﹤0.01% | 2908 |
|
|
2024
Q3 | $494K | Buy |
99,133
+3,733
| +4% | +$18.6K | ﹤0.01% | 2689 |
|
|
2024
Q2 | $558K | Sell |
95,400
-6,000
| -6% | -$35.1K | ﹤0.01% | 2555 |
|
|
2024
Q1 | $805K | Sell |
101,400
-19,000
| -16% | -$151K | ﹤0.01% | 2319 |
|
|
2023
Q4 | $702K | Buy |
120,400
+3,500
| +3% | +$20.4K | ﹤0.01% | 2368 |
|
|
2023
Q3 | $299K | Buy |
116,900
+17,900
| +18% | +$45.8K | ﹤0.01% | 2793 |
|
|
2023
Q2 | $248K | Buy |
+99,000
| New | +$248K | ﹤0.01% | 2934 |
|